N@N

Cecilia Furlong Maintained (ABT) at Buy with Increased Target to $157 on, Jan 7th, 2022

Cecilia Furlong of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $146 to $157 on, Jan 7th, 2022.

Cecilia has made no other calls on ABT in the last 4 months.

There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 2 agree with Cecilia's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $140 on, Thursday, October 21st, 2021
• Simon Baker of "Redburn Partners" Initiated at Hold on, Thursday, October 14th, 2021

These are the ratings of the 9 analyists that currently disagree with Cecilia

---

• Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $150 on, Wednesday, December 22nd, 2021
• Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $154 on, Wednesday, December 15th, 2021
• Shagun Singh of "RBC Capital" Initiated at Buy and Held Target at $146 on, Friday, December 10th, 2021
• James Mainwaring of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $144 on, Wednesday, October 27th, 2021
• Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $138 on, Thursday, October 21st, 2021
• Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $145 on, Thursday, October 21st, 2021
• Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $143 on, Wednesday, October 20th, 2021
• Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $135 on, Sunday, October 10th, 2021
• Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $140 on, Friday, October 8th, 2021

Contributing Sources

---